Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05550571 · ClinicalTrials.gov registry record · NA

A Medical Device to Treat Wide-Neck Brain Aneurysms

A NA study of Ruptured Cerebral Aneurysm, sponsored by EndoStream Medical.

Active
Registry status
NA
Development phase
45
Enrollment target
5
Study locations

NCT05550571 is a NA study of Ruptured Cerebral Aneurysm that is active but no longer recruiting, run by EndoStream Medical. The registered enrollment target is 45 participants. The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05550571, a NA study of Ruptured Cerebral Aneurysm, is active but no longer recruiting, sponsored by EndoStream Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
5
Study locations

Study Summary

The study aims to evaluate the safety and probable benefit of a medical device to treat wide-neck ruptured brain aneurysms.

Conditions Studied

Interventions

  • DEVICE Nautilus Intrasaccular Bridging System

Study Locations (5)

Florida

  • Baptist Health Ambulatory Services, Inc. d/b/a/ Baptist Health Research Institute - Jacksonville
  • University of South Florida - Tampa

New York

  • The research Foundation For The State Of New York On Behalf Of The University At Buffalo - Buffalo
  • Mount Sinai - New York

Sofia

  • UMHAT "Sv. Ivan Rilski" EAD - Sofia

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-12-17
Est. Completion 2026-10-01
Phase NA

Sponsor

EndoStream Medical

1 total trials

What the Registry Record Tells You About NCT05550571

The ClinicalTrials.gov registry entry for NCT05550571 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EndoStream Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ruptured Cerebral Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Nautilus Intrasaccular Bridging System is the first listed.

NCT05550571 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Florida, New York, Sofia.

Frequently Asked Questions

What is clinical trial NCT05550571 about?

NCT05550571 is a clinical study titled "A Medical Device to Treat Wide-Neck Brain Aneurysms". The study aims to evaluate the safety and probable benefit of a medical device to treat wide-neck ruptured brain aneurysms.

What is the current status of trial NCT05550571?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-12-17. Estimated completion is 2026-10-01.

What conditions does trial NCT05550571 study?

This clinical trial studies the following conditions: Ruptured Cerebral Aneurysm.

What interventions are being tested in trial NCT05550571?

The interventions under investigation include: Nautilus Intrasaccular Bridging System (DEVICE).

Who is sponsoring clinical trial NCT05550571?

This trial is sponsored by EndoStream Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05550571 being conducted?

This trial has 5 study locations across Florida, New York, Sofia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.